Investigation of the mechanisms of therapy-related hypoglycaemia in children with acute lymphoblastic leukaemia

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 1, 2003, Pages 37-42

  Halonen, Päivi ^a,b   Salo, M K ^b   Schmiegelow, K ^c   Makipernaa A ^d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c Rigshospitalet   (Denmark)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Acute lymphoblastic leukaemia; Fasting; Hypoglycaemia; Maintenance therapy

Indexed keywords

ALANINE; CARNITINE; DRUG METABOLITE; FATTY ACID; GLUTAMINE; MERCAPTOPURINE; METHOTREXATE;

ACIDURIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; HUMAN; HUMAN CELL; HYPOGLYCEMIA; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0037284915     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2003.tb00466.x     Document Type: Article

References (28)

1. Halonen P, Salo MK, Mäkipernaa A. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. J Pediatr 2001; 138: 428-31
2. LaFranchi S. Hypoglycemia of infancy and childhood. Pediatr Clin North Am 1987; 34: 961-82
3. Bonham JR. The investigation of hypoglycemia during childhood. Ann Clin Biochem 1993; 30: 238-47
4. Aynsley-Green A, McGann A, Deshpande S. Control of intermediary metabolism in childhood with special reference to hypoglycaemia and growth hormone. Acta Pædiatr Scand 1991; Suppl 377: 43-5
5. Lee PJ, Leonard JV. Hypoglycemia. In: Brook CGD, editor. Clinical paediatric endocrinology. 3rd ed. Cambridge: Blackwell Science Ltd, 1995. p. 677-93
6. Cahill GF Jr. Starvation in man. N Engl J Med 1970; 282: 668-75
7. Pagliara AS, Karl IE, Haymond M, Kipnis DM. Hypoglycemia in infancy and childhood I. J Pediatr 1973; 82: 365-79
8. Felig P. The glucose-alanine cycle. Metabolism 1973; 22: 179-207
9. Collipp PJ, Patrick JR, Gilchrist GS, Donnell GN, Brubaker C. Liver glucose-6-phosphatase and carbohydrate metabolism in childhood leukemia. Pediatr Res 1967; 1: 116-21
10. de Oliveira MB, Ishii EL, Yamamoto NS, Bracht AM, Campello A de P, Kluppel ML, et al. Methotrexate increases glycogenolysis in intact rat liver. Res Commun Chem Pathol Pharmacol 1986; 53: 173-81
11. Hudakova A, Horakova K, Perenyi T. The relation between the synergistic effect of cytostatics and metabolism of V 79B cells in vitro. Cell Biochem Function 1992; 10: 109-13
12. Chabner BA, Allegra CJ, Curt GA, Clendeninn NJ, Baram J, Koizumi S, et al. Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 1985; 76: 907-12
13. Tidd DM, Paterson AR. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 1974; 34: 738-46
14. Schmiegelow K, Schroder H, Schmiegelow M. Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell count or by pharmacokinetic parameters? Cancer Chemother Pharmacol 1994; 34: 209-15
15. Gustafsson G, Kreuger A, Clausen N, Garwicz S, Kristinsson J, Lie SO, et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Haematology and Oncology (NOPHO). Acta Pædiatr 1998; 87: 1151-61
16. Koh THHG, Aynsley-Green A, Tarbit M, Eyre JA. Neural dysfunction during hypoglycemia. Arch Dis Child 1988; 63: 1353-8
17. Cederblad G, Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta 1972; 37: 235-43
18. Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B, et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 1989; 26: 469-73
19. Remes AM, Rantala H, Hiltunen JK, Leisti J, Ruokonen A. Fumarase deficiency: two siblings with enlarged cerebral ventricles and polyhydramnions in utero. Pediatrics 1992; 89: 730-4
20. Kamen BA, Takach PL, Vatev R, Caston JD. A rapid, radiochemical-ligand binding assay for methotrexate. Anal Biochem 1976; 70: 54-63
21. Bruunshuus I, Schiemegelow K. Analysis of 6-mercaptopurine, 6-thioguanine nucleotides, and 6-thiouric acid in biological fluids by high-performance liquid chromatography. Scand J Clin Lab Invest 1989; 49: 779-84
22. Chaussain JL, Georges P, Olive G, Job JC. Glycemic response to 24-hour fast in normal children and children with ketotic hypoglycemia: II. Hormonal and metabolic changes. J Pediatr 1974; 85: 776-81
23. Frohlich J, Seccombe DW, Hahn P, Dodek P, Hynie I. Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and betahydroxybutyrate. Metabolism 1978; 27: 555-61
24. Saudubray JM, Marsac C, Limal JM, Dumurgier E, Charpentier C, Ogier H, et al. Variation in ketone plasma bodies during a 24-hour fast in normal and hypoglycemic children: relationship to age. J Pediatr 1981; 98: 904-8
25. Bonnefont JP, Specola NB, Vassault A, Lombes A, Ogier H, de Klerk JBC, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 1990; 150: 80-5
26. Chaussain JL. Glycemic response to 24-hour fast in normal children with ketotic hypoglycemia. J Pediatr 1973; 82: 438-43
27. Pagliara AS, Karl IE, DeVivo DC, Feigin RD, Kipnis DM. Hypoalaninemia: a concomitant of ketotic hypoglycemia. J Clin Invest 1972; 51: 1440-9
28. Haymond MW, Karl IE, Pagliara AS. Ketotic hypoglycemia: an amino acid substrate linked disorder. J Clin Endocrinol Metab 1974; 38: 521-30